• Publications
  • Influence
Circulating microRNAs in plasma of patients with gastric cancers
Background:We examined plasma microRNA (miRNA) concentrations from patients with gastric cancers (GCs) to assess their clinical application for diagnosing and monitoring diseases.Methods:We initiallyExpand
Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
Background:Several recent studies demonstrated that microRNAs (miRNAs) are stably detectable in plasma/serum. We hypothesised that plasma miRNAs concentrations contributed to potential biomarkers inExpand
Overexpression of SMYD2 relates to tumor cell proliferation and malignant outcome of esophageal squamous cell carcinoma.
Although we have identified two putative targets, ATF3 and CENPF, for a frequently gained/amplified region around 1q32-q41 in esophageal squamous cell carcinoma (ESCC), it is possible that otherExpand
Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer
Background:Several recent studies have demonstrated that microRNAs (miRNAs) are stably detectable in plasma/serum. We tested miR-221 and miR-375, which are frequently reported to be highly and poorlyExpand
Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
Background:Recently, it was reported that plasma microRNAs (miRNAs) are low-invasive useful biomarkers for cancer. We attempted to isolate gastric cancer (GC)-associated miRNAs comparing pre- andExpand
Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma
Background:Several recent studies demonstrated that microRNAs are stably detectable in plasma/serum. We tested whether miR-18a, which is located in the miR-17-92 cluster and reported to be highlyExpand
Circulating long non-coding RNAs in plasma of patients with gastric cancer.
BACKGROUND We examined the levels of long non-coding RNAs (lncRNAs) in the plasma of patients with gastric cancer to assess their clinical significance for diseases diagnosing and monitoring. Expand
Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer
BackgroundWe previously demonstrated the potential of circulating tumor DNA (ctDNA) for the amplification of detecting HER2 in patients with gastric cancer (GC). In the present study, we focused onExpand
Surgical Outcomes of Gastrectomy for Elderly Patients with Gastric Cancer
BackgroundThis study was designed to determine the surgical outcomes of gastric cancer in elderly patients. This information can help establish appropriate treatment for these patients.MethodsA totalExpand
Circulating miR-18a: a sensitive cancer screening biomarker in human cancer.
MicroRNAs have been reported to be stably detectable in plasma/serum and to exhibit resistance to endogenous ribonuclease activity because of binding to proteins such as Argonaute-2 and high-densityExpand
...
1
2
3
4
5
...